Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Plos One|September 26, 2013
Restriction genes for retroviruses influence the risk of multiple sclerosisBjørn A Nexø, Bettina Hansen, Kari K Nissen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 29, 2017
Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?Tue Kjølhede, Susanne Siemonsen, Damian Wenzel, et al.
Plos One|November 1, 2011
Genetic association of multiple sclerosis with the marker rs391745 near the endogenous retroviral locus HERV-Fc1: analysis of disease subtypesBettina Hansen, Annette B Oturai, Hanne F Harbo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2018
Can we trust self-reported walking distance when determining EDSS scores in patients with multiple sclerosis? The Danish MS hospitals rehabilitation studyAnders Guldhammer Skjerbæk, Finn Boesen, Thor Petersen, et al.
Neurology|December 2, 2020
Efficacy of High-Intensity Aerobic Exercise on Brain MRI Measures in Multiple SclerosisMartin Langeskov-Christensen, Lars Grøndahl Hvid, Mikkel Karl Emil Nygaard, et al.
Lancet (London, England)|October 22, 2003
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosisPer Soelberg Sorensen, Christian Ross, Katja Maria Clemmesen, et al.
Brain Sciences|September 28, 2021
The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled TrialJulie Schjødtz Hansen, Rikke Middelhede Hansen, Thor Petersen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES)Morten Riemenschneider, Lars G Hvid, Steffen Ringgaard, et al.
Clinical and Translational Science|December 6, 2023
Pharmacokinetics and pharmacodynamics of cannabis-based medicine in a patient population included in a randomized, placebo-controlled, clinical trialJulie Schjødtz Hansen, Fernando Boix, Jørgen Bo Hasselstrøm, et al.
Multiple Sclerosis and Related Disorders|March 13, 2021
Population-based head-to-head comparison of the clinical characteristics and epidemiology of AQP4 antibody-positive NMOSD between two European countriesPapp Viktoria, Kim D P Trones, Melinda Magyari, et al.
Pageof 10